l-Carnitine: A Preliminary Review of its Pharmacokinetics, and its Therapeutic Use in Ischaemic Cardiac Disease and Primary and Secondary Carnitine Deficiencies in Relationship to its Role in Fatty Acid Metabolism

Drugs

Volumn 34, Issue 1, 1987, Pages 1-24

  Goa, Karen L ^a   Brogden, Rex N ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BICARNESINE; CARNICOR; CARNITAN; CARNITINE; CARRIER; DISOCOR; FLATISTINE; GLYCERYL TRINITRATE; MONOCAMIN; PREDNISONE; UNCLASSIFIED DRUG;

ADVERSE DRUG REACTION; ANGINA PECTORIS; CARDIOVASCULAR SYSTEM; DIGESTIVE SYSTEM; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; FATTY ACID METABOLISM; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HEART; HEART ARRHYTHMIA; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEMODYNAMICS; HUMAN; HYPERLIPOPROTEINEMIA; INTOXICATION; MUSCLE; MYASTHENIA; MYOPATHY; NEWBORN; PHARMACOKINETICS; PRIORITY JOURNAL; REVIEW; REYE SYNDROME;

CARNITINE; CORONARY DISEASE; FATTY ACIDS; HUMAN;

EID: 0023185385     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/00003495-198734010-00001     Document Type: Article

References (133)

1. Effect of carnitine on serum triglycerides in alcoholism: a double-blind placebo controlled trial
2. Endocrine-metabolic effects of l-carnitine in patients on regular dialysis treatment
3. Carnitine prevention of adri-amycin in toxicity in mice
4. Autosomal recessive lipid storage myopathy (probable carnitine deficiency)
5. Carnitine deficiency of skeletal muscle: report of a treated case
6. Clinical study of efficacy of l-carnitine and metabolic observations in exercise physiology
7. Carnitine supplementation in human carnitine deficiency
8. Carnitine in haemodialysis patients
9. Carnitine in human nutrition
10. Free and total carnitine in human serum after oral ingestion of l-carnitine
11. Erfahrungen mit 1-camitin in der post-aggressions phase
12. Hussey JL, Shrago E. Perturbation of serum carnitine levels in human adults by chronic renal disease and dialysis therapy
13. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes
14. Myasthenialike syndrome after dl- but not l-carnitine
15. Correlation between increased serum and tissue l-carnitine levels and improved muscle symptoms in hemodialyzed physiokinesiotherapy in chronic respiratory insufficiency
16. Changes in physical performance of untrained volunteers: effects of l-carnitine
17. Myasthenia due to carnitine treatment
18. Reduction of cardiac toxicity of anthracyclines by l-carnitine: preliminary overview of clinical data
19. Evidence for autosomal recessive inheritance in systemic carnitine deficiency
20. Systemic carnitine deficiency: clinical, biochemical, and morphological cure with l-carnitine
21. Propionylcarnitine excretion in propionic acid and methylmalonic acidurias: a cause of carnitine deficiency
22. La camitina nel trattamento dei crampi muscolari nei pazienti in emodialisi periodica
23. Effects of l-carnitine on chronic anaemia and erythrocyte adenosine triphosphate (ATP) concentration in haemodialysed patients
24. Carnitine deficiency of human muscle with associated lipid storage myopathy — a new syndrome
25. Primary systemic carnitine deficiency. II. Renal handling of carnitine
26. Systemic carnitine deficiency exacerbated by a strict vegetarian diet
27. Carnitine and left ventricular function in haemodialysis patients
28. l-Carnitine and haemodialysis: double-blind study on muscle function and metabolism and peripheral nerve function
29. The effect of l-carnitine (camitene) on myocardial metabolism of patients with coronary artery disease
30. Effect of fasting on free and esterified carnitine levels in human serum and urine: correlation with serum levels of free fatty acids and β-hydroxybutyrate
31. Polygraphic evaluation of effects of carnitine in patients on adriamycin treatment
32. Comparative study on the activity of racemic and laevorotatory carnitine in stable angina pectoris
33. Reye-like syndrome associated with valproic acid
34. Myopathie congénitale avec surcharge de la fibre musculaire en lipids et glycogene et déficit partiel en carnitine
35. Effect of l-carnitine on systolic time intervals in coronary artery disease
36. Systemic carnitine deficiency simulating recurrent Reye syndrome
37. Hypoglycemia, hepatic dysfunction, muscle weakness, cardiomyopathy, free carnitine deficiency and long-chain acylcamitine excess responsive to medium chain triglyceride diet
38. Absorption of D and L-camitine by the intestine and kidney tubule in the rat
39. Plasma carnitine levels during total parenteral nutrition of adult surgical patients
40. Carnitine transport in human intestinal biopsy specimens
41. Enhanced lipid utilization in infants receiving oral l-carnitine during long-term parenteral nutrition
42. A case history of myopathic carnitine deficiency benefited by glucocorticoids and l-carnitine supplementation
43. Effects of l-carnitine on exercise tolerance in patients with stable angina pectoris
44. Metabolic effects of treatment of systemic carnitine deficiency
45. The role of l-carnitine in the pathogenesis of cardiomegaly in patients with chronic hemodialysis
46. Plasma l-carnitine in patients with chronic hemodialysis — pharmacokinetics of l-carnitine and its replacement therapy in these patients
47. Quantitative assessment of carnitine loss during hemodialysis and hemofiltration
48. Metabolism of the ischemic heart: alterations in fatty acid intermediates and role of carnitine
49. Metabolic regulation and myocardial function
50. Metabolic regulation and myocardial function
51. Metabolic regulation and myocardial function
52. Antagonism of doxorubicin cardiotoxicity by camidine is specific of the 1-diasteriosomer
53. Urinary excretion of carnitine in man
54. Effect of aging on lipid and carnitine metabolism
55. Myocardiopathie familiale par déficit en carnitine
56. Effects of l-carnitine loading on the aerobic and anaerobic performance of endurance athletes
57. Muscle carnitine deficiency
58. Un cas de myopathie avec déficit en carnitine
59. Successful carnitine treatment in two siblings having lipid storage myopathy with hypertrophic cardiomyopathy
60. An improved and simplified radioisotopic assay for the determination of free and esterified carnitine
61. 14C in normal, alloxan diabetic and insulin treated rats
62. Use of dl- and l-carnitine in uraemic patients on intermittent haemodialysis
63. Carnitine plasma levels during total parenteral nutrition
64. Protective effect of l-carnitine on cardiac metabolic damage induced by doxorubicin in vitro
65. Creatin kinase-MB: a non-invasive test monitoring acute adriamycin and daunomycin cardiotoxicity
66. Protective effects of l-carnitine (camitene) on acute adriamycin and daunomycin cardiotoxicity in cancer patients
67. Plasma lipoproteins, liver function and glucose metabolism in haemodialysis patients: lack of effect of 1-carnitine supplementation
68. Free fatty acids and carnitine in patients with liver disease
69. Carnitine in the perinatal metabolism of lipids 1. Relationship between maternal and fetal plasma levels of carnitine and arylcamitines
70. Carnitine deficiency and hyperammonemia associated with valproic acid therapy
71. Role of carnitine in fatty acid metabolism of normal and ischemic myocardium
72. Effect of carnitine on lipid metabolism in the neonate. II. Carnitine addition to lipid infusion during prolonged total parenteral nutrition
73. Encephalopathy and fatal myopathy in two siblings
74. A hereditary case of lipid storage myopathy with carnitine deficiency
75. Decreased tissue carnitine concentrations in newborn infants receiving total parenteral nutrition
76. Possible carnitine deficiency in parenterally alimented newborn infants
77. Parenteral Nutrition: current status and concepts
78. Carnitine in the therapy of dyslipidemie patients
79. Statistical evaluation of long-term l-carnitine therapy in hyperlipoproteinaemias
80. Klinische, morphologische und biochemische befunde bei carnitinmangelmyopathien
81. Carnitine metabolism and deficiency syndromes
82. Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes
83. L-camitine dissimilation in the gastrointestinal tract of the rat
84. Beneficial effects of l-carnitine in the reduction of the necrotic area in acute myocardial infarction
85. Evaluation of the effects of high doses of l-carnitine on the myocardial lactate balance during pacing-induced ischemia in ageing subjects
86. Effects of carnitine administration in patients with chronic renal failure undergoing periodic dialysis, evaluated by computerized electromyography
87. Carnitine deficiency in haemodialysed patients
88. L-camitine enhances excretion of propionyl coenzyme A as propionylcamitine in propionic acidemia
89. Metabolic response to carnitine in methylmalonic aciduria
90. Effect of carnitine on serum HDL-cholesterol: report of two cases
91. Postheparin plasma lipases and carnitine in infants during parenteral nutrition
92. Blood levels of total carnitine and lipid utilization with and without carnitine supplementation in newborn infants
93. Ameliorating effects of carnitine and its precursors on alcohol-induced fatty liver
94. Carnitine levels in skeletal muscle of malnourished patients before and after total parenteral nutrition
95. Carnitine deficiency and lipid storage myopathy in three patients: analysis of some differential features
96. Cardiodynamic effects of l-carnitine in ischaemic cardiopathy
97. Plasma carnitine levels during intravenous feeding of the neonate
98. Carnitine and neonatal lipid metabolism
99. Transfer and metabolism of carnitine and carnitine esters in the in vitro perfused placenta
100. Carnitine deficiency in premature infants receiving total parenteral nutrition: effect of l-carnitine supplementation
101. Esperienza con 1-camitina nel trattamento della angina stabile da sforzo
102. Familial carnitine deficiency
103. L-camitine for methyl-malonicaciduria
104. L-camitine treatment in glutaric aciduria type I
105. Biochemical derangements in ischemic myocardium: the role of carnitine
106. Nonketotic hypoglycemia: an early indicator of systemic carnitine deficiency
107. Successful treatment of familial idiopathic lipid storage myopathy with l-carnitine and modified lipid diet
108. Myocardial carnitine deficiency in acute myocardial infarction
109. Carnitine deficiency with valproate therapy
110. Serum and urinary carnitine and organic acids in Reye syndrome and Reye-like syndrome
111. Effects of carnitine administration, fasting, and exercise on urinary carnitine excretion in man
112. Lipid metabolism in parenterally alimented neonates: carnitine blood concentrations and fat utilization
113. Urinary carnitine excretion in surgical patients on total parenteral nutrition
114. Carnitine metabolism and its application in parenteral nutrition
115. Improved pacing tolerance of the ischemic human myocardium after administration of carnitine
116. Systemic carnitine deficiency presenting as familial endocardial fibroelastosis
117. Longterm l-carnitine treatment of chronic anaemia of patients with end-stage renal failure
118. Favorable effects of l-carnitine treatment on hypertriglyceridemia in hemodialysis patients: decisive role of low levels of high-density lipoprotein-cholesterol
119. Serum and muscle l-carnitine levels in hemodialyzed patients during and after long-term l-carnitine treatment
120. Hereditary carnitine deficiency of muscle
121. Treatment with l-carnitine in hemodialysis patients
122. Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport
123. Potential role of carnitine in patients with renal insufficiency
124. Systemic carnitine deficiency. Report of a fatal case with multisystemic manifestations
125. Pharmacokinetics of l-carnitine in man following intravenous infusion of dl carnitine
126. High dose of l-carnitine increases platelet aggregation and plasma triglyceride levels in uremic patients on hemodialysis
127. Tissue Carnitine in Reye syndrome
128. Carnitine balance and effects of intravenous l-carnitine in two patients receiving long-term total parenteral nutrition
129. Fetal Reye-like syndrome associated with valproic acid